The National Institute for Health and Care Excellence (NICE) has recommended Santhera Pharmaceuticals’ Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD). The drug has been recommended ...

Regeneron Pharmaceuticals has shared positive data from a phase 3 trial of pozelimab plus cemdisiran (poze-cemdi) in patients ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

Amgen has announced a $1bn investment to establish a second US drug substance manufacturing facility in North Carolina. The ...

To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business approaches, Genesis Research Group employed their RPR stakeholder engagement ...

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies: Torre Lazur, expert in Rx, ethical, medical device marketing ...

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client needs. Our integrated ...

Product which is licensed for purchase by the general public but only from a pharmacy.

Refers to any of the Food and Drug Administration (FDA) procedures, such as compassionate use, parallel track, and treatment IND that distribute experimental drugs to participants who are failing on ...

Formerly the professional body for pharmacists and the regulatory body for pharmacists and pharmacy technicians in England, Scotland and Wales. In September 2010, the regulatory powers of the Society ...

Healthcare that is provided by professionals who do not usually have first contact with patients. This type of care is usually delivered in hospitals or clinics after patients have been referred by ...